Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 3, 2015Chemical Communications

Pharmaceutical cocrystals: along the path to improved medicines

View Full Paper
Ask AI
Bookmark
Share

Authors

NDNaga Kiran DuggiralaUniversity of MinnesotaMPMiranda L. PerryUniversity of LimerickÖAÖrn AlmarssonAlkermes (Ireland)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Duggirala et al. (2015) studied this question.

synapsesocial.com/papers/69f5877d4353f6f78dafbdabhttps://doi.org/10.1039/c5cc08216a
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Supramolecular synthons in phenol–isonicotinamide adducts2003 · 104 citations
  2. 2The a to Z of Pharmaceutical Cocrystals: A Decade of Fast-Moving New Science and Patents2012 · 101 citations
  3. 3Development of an Early-Phase Bulk Enabling Route to Sodium-Dependent Glucose Cotransporter 2 Inhibitor Ertugliflozin2014 · 45 citations
  4. 4The crystal structure of the acid salts of some monobasic acids. Part III. Potassium hydrogen dibenzoate1954 · 31 citations
  5. 5One in half a million: a solid form informatics study of a pharmaceutical crystal structure2011 · 51 citations